Bausch & Lomb Analyst Ratings
Bausch & Lomb Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/06/2023 | 22.38% | HC Wainwright & Co. | $22 → $21 | Reiterates | Buy → Buy |
| 10/03/2023 | 16.55% | Evercore ISI Group | → $20 | Reinstates | → Outperform |
| 08/04/2023 | 28.21% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
| 08/03/2023 | 16.55% | Morgan Stanley | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight |
| 08/03/2023 | 10.72% | Barclays | $18 → $19 | Maintains | Equal-Weight |
| 07/24/2023 | 22.38% | RBC Capital | $20 → $21 | Maintains | Outperform |
| 07/10/2023 | 34.03% | Citigroup | $22 → $23 | Maintains | Buy |
| 07/03/2023 | 34.03% | B of A Securities | $19 → $23 | Maintains | Buy |
| 07/03/2023 | 28.21% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
| 05/30/2023 | 16.55% | Morgan Stanley | → $20 | Assumes | → Equal-Weight |
| 05/19/2023 | 28.21% | HC Wainwright & Co. | $19 → $22 | Maintains | Buy |
| 05/05/2023 | 10.72% | HC Wainwright & Co. | $21 → $19 | Maintains | Buy |
| 05/05/2023 | 4.9% | Barclays | $17 → $18 | Maintains | Equal-Weight |
| 05/04/2023 | 16.55% | RBC Capital | → $20 | Reiterates | → Outperform |
| 03/23/2023 | 22.38% | HC Wainwright & Co. | → $21 | Reiterates | → Buy |
| 03/09/2023 | — | Needham | Initiates Coverage On | → Hold | |
| 02/24/2023 | 22.38% | HC Wainwright & Co. | $20 → $21 | Maintains | Buy |
| 02/23/2023 | -0.93% | JP Morgan | $15 → $17 | Maintains | Neutral |
| 02/23/2023 | 16.55% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight |
| 02/23/2023 | 16.55% | RBC Capital | → $20 | Reiterates | → Outperform |
| 02/15/2023 | 16.55% | RBC Capital | $17 → $20 | Maintains | Outperform |
| 02/02/2023 | 16.55% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 12/21/2022 | -0.93% | Barclays | → $17 | Initiates Coverage On | → Equal-Weight |
| 11/23/2022 | -0.93% | Goldman Sachs | $19 → $17 | Maintains | Neutral |
| 11/03/2022 | -12.59% | JP Morgan | $16 → $15 | Maintains | Neutral |
| 11/03/2022 | -0.93% | RBC Capital | $18 → $17 | Maintains | Outperform |
| 11/03/2022 | 4.9% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight |
| 11/03/2022 | 16.55% | HC Wainwright & Co. | $21 → $20 | Maintains | Buy |
| 10/11/2022 | 10.72% | Morgan Stanley | $20 → $19 | Maintains | Equal-Weight |
| 09/12/2022 | 22.38% | HC Wainwright & Co. | → $21 | Initiates Coverage On | → Buy |
| 08/16/2022 | 10.72% | Goldman Sachs | $22 → $19 | Maintains | Neutral |
| 07/26/2022 | 28.21% | RBC Capital | → $22 | Initiates Coverage On | → Outperform |
| 06/24/2022 | 22.38% | Evercore ISI Group | → $21 | Initiates Coverage On | → Outperform |
| 06/09/2022 | 16.55% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
| 06/06/2022 | 28.21% | Citigroup | → $22 | Initiates Coverage On | → Buy |
| 05/31/2022 | 28.21% | Morgan Stanley | → $22 | Initiates Coverage On | → Equal-Weight |
| 05/31/2022 | 28.21% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
| 05/31/2022 | 39.86% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 05/31/2022 | 34.03% | Wells Fargo | → $23 | Initiates Coverage On | → Overweight |
| 05/11/2022 | 103.96% | Cowen & Co. | → $35 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/06/2023 | 22.38% | HC Wainwright公司 | $22→$21 | 重申 | 购买→购买 |
| 10/03/2023 | 16.55% | Evercore ISI集团 | →$20 | 恢复 | →跑赢大盘 |
| 08/04/2023 | 28.21% | HC Wainwright公司 | →$22 | 重申 | 购买→购买 |
| 08/03/2023 | 16.55% | 摩根士丹利 | $20→$20 | 重申 | 等重→等重 |
| 08/03/2023 | 10.72% | 巴克莱 | $18→$19 | 维护 | 等重 |
| 07/24/2023 | 22.38% | 加拿大皇家银行资本 | $20→$21 | 维护 | 跑赢大盘 |
| 07/10/2023 | 34.03% | 花旗集团 | $22→$23 | 维护 | 买 |
| 07/03/2023 | 34.03% | B of A证券 | $19→$23 | 维护 | 买 |
| 07/03/2023 | 28.21% | HC Wainwright公司 | →$22 | 重申 | 购买→购买 |
| 2023年05月30日 | 16.55% | 摩根士丹利 | →$20 | 假设 | →等重 |
| 2023年05月19日 | 28.21% | HC Wainwright公司 | $19→$22 | 维护 | 买 |
| 05/05/2023 | 10.72% | HC Wainwright公司 | $21→$19 | 维护 | 买 |
| 05/05/2023 | 4.9% | 巴克莱 | $17→$18 | 维护 | 等重 |
| 05/04/2023 | 16.55% | 加拿大皇家银行资本 | →$20 | 重申 | →跑赢大盘 |
| 03/23/2023 | 22.38% | HC Wainwright公司 | →$21 | 重申 | →购买 |
| 03/09/2023 | - | 李约瑟 | 开始承保 | →保留 | |
| 02/24/2023 | 22.38% | HC Wainwright公司 | $20→$21 | 维护 | 买 |
| 02/23/2023 | -0.93% | 摩根大通 | $15→$17 | 维护 | 中性 |
| 02/23/2023 | 16.55% | 摩根士丹利 | $18→$20 | 维护 | 等重 |
| 02/23/2023 | 16.55% | 加拿大皇家银行资本 | →$20 | 重申 | →跑赢大盘 |
| 02/15/2023 | 16.55% | 加拿大皇家银行资本 | $17→$20 | 维护 | 跑赢大盘 |
| 02/02/2023 | 16.55% | HC Wainwright公司 | →$20 | 重申 | →购买 |
| 2022年12月21日 | -0.93% | 巴克莱 | →$17 | 开始承保 | →等重 |
| 2022年11月23日 | -0.93% | 高盛 | $19→$17 | 维护 | 中性 |
| 11/03/2022 | -12.59% | 摩根大通 | $16→$15 | 维护 | 中性 |
| 11/03/2022 | -0.93% | 加拿大皇家银行资本 | $18→$17 | 维护 | 跑赢大盘 |
| 11/03/2022 | 4.9% | 摩根士丹利 | $19→$18 | 维护 | 等重 |
| 11/03/2022 | 16.55% | HC Wainwright公司 | $21→$20 | 维护 | 买 |
| 2022年10月11日 | 10.72% | 摩根士丹利 | $20→$19 | 维护 | 等重 |
| 09/12/2022 | 22.38% | HC Wainwright公司 | →$21 | 开始承保 | →购买 |
| 08/16/2022 | 10.72% | 高盛 | $22→$19 | 维护 | 中性 |
| 07/26/2022 | 28.21% | 加拿大皇家银行资本 | →$22 | 开始承保 | →跑赢大盘 |
| 2022/06/24 | 22.38% | Evercore ISI集团 | →$21 | 开始承保 | →跑赢大盘 |
| 06/09/2022 | 16.55% | 摩根士丹利 | $22→$20 | 维护 | 等重 |
| 06/06/2022 | 28.21% | 花旗集团 | →$22 | 开始承保 | →购买 |
| 2022年05月31日 | 28.21% | 摩根士丹利 | →$22 | 开始承保 | →等重 |
| 2022年05月31日 | 28.21% | 高盛 | →$22 | 开始承保 | →中性 |
| 2022年05月31日 | 39.86% | 古根海姆 | →$24 | 开始承保 | →购买 |
| 2022年05月31日 | 34.03% | 富国银行 | →$23 | 开始承保 | →超重 |
| 2022年05月11日 | 103.96% | 考恩公司 | →$35 | 开始承保 | →跑赢大盘 |
What is the target price for Bausch & Lomb (BLCO)?
博士伦的目标价是多少？
The latest price target for Bausch & Lomb (NYSE: BLCO) was reported by HC Wainwright & Co. on October 6, 2023. The analyst firm set a price target for $21.00 expecting BLCO to rise to within 12 months (a possible 22.38% upside). 29 analyst firms have reported ratings in the last year.
博士伦(纽约证券交易所代码：BLCO)的最新目标价是由HC Wainwright&Co.于2023年10月6日报道的。这家分析公司将目标价定为21.00美元，预计BLCO将在12个月内上涨至22.38%(可能上涨22.38%)。去年有29家分析公司公布了评级。
What is the most recent analyst rating for Bausch & Lomb (BLCO)?
博士伦(Bausch&Lomb)最近的分析师评级是多少？
The latest analyst rating for Bausch & Lomb (NYSE: BLCO) was provided by HC Wainwright & Co., and Bausch & Lomb reiterated their buy rating.
博士伦(纽约证券交易所代码：BLCO)的最新分析师评级是由HC Wainwright&Co.提供的，博士伦重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Bausch & Lomb (BLCO)?
博士伦(Bausch&Lomb)的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch & Lomb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch & Lomb was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查看公开的财务报表，与博士伦的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。博士伦的上一次评级是在2023年10月6日提交的，因此你应该预计下一次评级将在2024年10月6日左右公布。
Is the Analyst Rating Bausch & Lomb (BLCO) correct?
分析师对博士伦的评级正确吗？
While ratings are subjective and will change, the latest Bausch & Lomb (BLCO) rating was a reiterated with a price target of $22.00 to $21.00. The current price Bausch & Lomb (BLCO) is trading at is $17.16, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但博士伦(BLCO)的最新评级重申了目标价在22.00美元至21.00美元之间。博士伦目前的股价为17.16美元，超出了分析师的预期区间。